Günay Ezel, Sarıkaya Selda, Özdolap Şenay, Büyükuysal Çağatay
Department of Physical and Rehabilitation Medicine, Bülent Ecevit University Medical School, Zonguldak, Turkey.
Department of Biostatistics, Bülent Ecevit University Medical School, Zonguldak, Turkey.
Turk J Phys Med Rehabil. 2017 Nov 27;63(4):299-306. doi: 10.5606/tftrd.2017.711. eCollection 2017 Dec.
This study aims to evaluate the effect of kinesiotaping implementation on pain and functional status in patellofemoral pain syndrome (PFPS).
Between January 2014 and July 2014, this prospective, single-center, randomized-controlled study included a total of 75 knees from 43 patients (20 males, 23 females; mean age 33.8±7.9 years; range, 20 to 50 years). All patients were divided into three treatment groups: Group 1 (25 knees) were treated with kinesiotaping and exercise, Group 2 (25 knees) were treated with sham taping + and exercise, and Group 3 (25 knees) were treated with exercise alone. The Visual Analog Scale (VAS) was used to assess the pain severity. The Kujala Patellofemoral Scale (KPS) was used to determine the effect of the knee pain on the patients' daily living activities. All three groups were given the same exercise program during six weeks. Kinesiotaping was applied twice a week, 12 times in total during the treatment period of six weeks. The VAS and KPS assessments for all patients were made at baseline, then at the end of the treatment (week 6) and at week 12 the end of the 12th week.
There were no statistically significant differences between the three groups in terms of age, sex, height, weight, and Body Mass Index (p>0.05, for all). A statistically significant improvement was observed in all groups in terms of the mean VAS and KPS scores before the treatment, at week 6, and at week 12 (p<0.001, for all). There was no statistically significant change in the mean changes of the VAS and KPS among the groups at week 6 and 12.
Our study results suggest that the addition of the kinesiotaping application to the exercise treatment for PFPS seems to be ineffective on pain control and improved daily life activities.
本研究旨在评估肌内效贴布疗法对髌股疼痛综合征（PFPS）患者疼痛及功能状态的影响。
2014年1月至2014年7月，这项前瞻性、单中心、随机对照研究共纳入43例患者的75个膝关节（男性20例，女性23例；平均年龄33.8±7.9岁；范围20至50岁）。所有患者被分为三个治疗组：第1组（25个膝关节）接受肌内效贴布疗法及运动治疗，第2组（25个膝关节）接受假贴布+运动治疗，第3组（25个膝关节）仅接受运动治疗。采用视觉模拟评分法（VAS）评估疼痛严重程度。使用库贾拉髌股评分量表（KPS）确定膝关节疼痛对患者日常生活活动的影响。所有三组在六周内接受相同的运动方案。肌内效贴布每周应用两次，在六周的治疗期内共应用12次。对所有患者的VAS和KPS评估在基线时进行，然后在治疗结束时（第6周）以及第12周结束时进行。
三组在年龄、性别、身高、体重和体重指数方面无统计学显著差异（所有p>0.05）。在治疗前、第6周和第12周，所有组的平均VAS和KPS评分均有统计学显著改善（所有p<0.001）。在第6周和第12周，各组间VAS和KPS的平均变化无统计学显著差异。
我们的研究结果表明，在PFPS的运动治疗中添加肌内效贴布疗法似乎对疼痛控制和改善日常生活活动无效。
